The Dutch Cancer Society (KWF Kankerbestrijding) has announced on December 20th an investment of € 49.7 million in cancer research. Two million of this budget will go to 3 research projects at the Amsterdam institute for Infection and Immunity.
This year, the KWF has organized funding in themes they have chosen to accelerate. These include:
- Exploration: basic laboratory research
- Development: the translation of insights to the patient
- Implementation: applying and scaling up research results in practice
- Smart Measurement: theme call focused on new, smart techniques to monitor cancer during and after treatment
- Palliative Care: theme call aimed at better care in the last phase of life
- Public-Private partnerships
The Amsterdam institute for Infection and Immunity funded research projects all fall within the 'Exploration' theme.
Funded research projects
- Sandra van Vliet: The role of FUT9 in the anti-tumor immune activity in colorectal cancer (€ 545,827)
- Arjan Griffioen: VICI: Overcoming cancer with immunotherapy by removing the blood vessel barrier (€ 908,857.10)
Young Investigator Grant
- Lotte de Winde: New treatments for patients with aggressive lymphoma that inhibit the tumor-promoting function of fibroblasts in the lymph node (€ 611,399)
About KWF
The Dutch Cancer Society is committed to fight cancer by scientific research, education, patient support and fundraising in cooperation with volunteers, donors, patients, doctors and researchers. KWF aims to achieve less cancer, more cures and a higher quality of life for cancer patients.
Read more on the KWF webpage and on the Amsterdam UMC webpage.
For more information, contact Amsterdam institute for Infection and Immunity.